Scopus BioPharma (CE) Stock Quote SCPS - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.0003

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.000001 52 Week Range 0.068

Market Cap

12.625k

Previous Close

0.0003

Open

Last Trade

0.0003

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,693

Shares Outstanding

42,084,264

Dividend Yield

PE Ratio

-0.62

Earnings Per Share (EPS)

-0.28

Revenue

Net Profit

-11.61M

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.scopusbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Scopus BioPharma Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker SCPS. The last closing price for Scopus BioPharma (CE) was $0. Over the last year, Scopus BioPharma (CE) shares have traded in a share price range of $ 0.000001 to $ 0.068.

Scopus BioPharma (CE) currently has 42,084,264 shares outstanding. The market capitalization of Scopus BioPharma (CE) is $12,625.28 . Scopus BioPharma (CE) has a price to earnings ratio (PE ratio) of -0.62.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.0003	0.0003	0.0003	662	0.0003	CS
4	0.0001	50	0.0002	0.0003	0.0001	1531	0.000255	CS
12	0.0001	50	0.0002	0.0003	1.0E-6	1693	0.00017084	CS
26	-0.0019	-86.3636363636	0.0022	0.0034	1.0E-6	3939	0.00103134	CS
52	-0.0397	-99.25	0.04	0.068	1.0E-6	8076	0.03712449	CS
156	-0.0848	-99.6474735605	0.0851	0.156	1.0E-6	26105	0.07989215	CS
260	-0.0848	-99.6474735605	0.0851	0.156	1.0E-6	26105	0.07989215	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WNBDWinning Brands Corporation (PK)	$ 0.0001 (9,900.00%)	500k
SGYIStrategy International Insurance Group Inc (CE)	$ 0.0001 (9,900.00%)	20.1k
ERGOEntia Biosciences Inc (CE)	$ 0.0001 (9,900.00%)	100
IMTLImage Protect Inc (PK)	$ 0.0001 (9,900.00%)	14.24M
AMHGQAmergent Hospitality Group Inc (CE)	$ 0.0001 (9,900.00%)	114.1k
LBWRLabwire Inc (CE)	$ 0.000001 (-99.95%)	300k
FBECFBEC Worldwide Inc (CE)	$ 0.000001 (-99.90%)	1.51M
ERHEERHC Energy Inc (CE)	$ 0.000001 (-99.83%)	500k
GMVDFG Medical Innovations Holdings Ltd (CE)	$ 0.000001 (-99.80%)	8.11k
DVFIDiversified Oil and Gas Holdings Limited (CE)	$ 0.000001 (-99.50%)	150k
HCMCHealthier Choices Management Corporation (PK)	$ 0.0001 (100.00%)	521.25M
ASIIAccredited Solutions Inc (PK)	$ 0.0008 (-15.79%)	270.16M
CGACCode Green Apparel Corp (PK)	$ 0.0001 (0.00%)	159.49M
HMBLHUMBL Inc (PK)	$ 0.00024 (-20.00%)	158.23M
PSRUValiant Eagle Inc (PK)	$ 0.00016 (60.00%)	126.84M